About Redoxis

Redoxis is a leading contract research organization specializing in preclinical drug development services. With a strong focus on inflammatory and autoimmune diseases, we provide high-quality in vitro and in vivo studies to support early-stage drug discovery and efficacy evaluation.

At Redoxis, we offer a broad range of expertise in different drug modalities, including small molecules, biologics, cell and gene therapies, and mRNA-based treatments. Our state-of-the-art laboratory facilities and dedicated team enable us to deliver reliable and reproducible data to accelerate the development of innovative therapeutics.

With a commitment to scientific excellence and customer collaboration, Redoxis partners with biotech and pharmaceutical companies worldwide. Our goal is to advance the development of next-generation treatments by providing reliable preclinical data and expert guidance throughout the drug discovery process.

Contact us to learn more about how Redoxis can support your research and drug development needs.

Customer Reviews

  • \"Redoxis is a much-appreciated partner for preclinical efficacy evaluation of our candidate drug in rodents, always professional and ready to interact and share their expertise with great commitment.\"

    Susanne Lindquist

    CSO Lipum AB

  • \"We highly appreciate the scientific expertise and problem solving skills combined with flexibility and service commitment shown by the Redoxis team. We are very satisfied with the studies performed both in vitro and in vivo and look forward to continued and extended collaborations.\"

    Susanna Dahlgren, Senior Director Project Management

    Aqilion AB

  • \"It was a real pleasure to communi­cate with Redoxis team and the performed studies fit very well to our expectancies. In other words, we are fully satisfied.\"

    Sebastian Hannedouche

    Euroscreen, Belgium

More Reviews

Contact us

Inquiries? Questions?

Nina Woodworth

COO